Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells: Involvement of Mitogen-Activated Protein Kinases

Chandrasekharam N. Nagineni, William Samuel, Sahrudaya Nagineni, Komanduri Pardhasaradhi, Barbara Wiggert, Barbara Detrick, John J. Hooks

Research output: Contribution to journalArticle

Abstract

Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age-related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a critical role in retinal disorders. We have examined the effects of various growth factors on the expression and secretion of VEGF by human retinal pigment epithelial cell cultures (HRPE). RT-PCR analyses revealed the presence of three isoforms of mRNA corresponding to VEGF 121, 165, and 189 that were up regulated by TGF-β1. TGF-β1, β2, and β3 were the potent inducers of VEGF secretion by HRPE cells whereas bFGF, PDGF, TGF-α, and GM-CSF had no effects. TGF-β receptor type II antibody significantly reversed induction of VEGF secretion by TGF-β. In contrast activin, inhibin and BMP, members of TGF-β super family, had no effects on VEGF expression in HRPE. VEGF mRNA levels and protein secretion induced by TGF-β were significantly inhibited by SB203580 and U0126, inhibitors of MAP kinases, but not by staurosporine and PDTC, protein kinase C and NF-κB pathway inhibitors, respectively. TGF-β also induced VEGF expression by fibroblasts derived from human choroid of eye. TGF-β induction of VEGF secretion by RPE and choroid cells may play a significant role in choroidal neovascularization (CNV) in AMD. Since the secretion of VEGF by HRPE is regulated by MAP kinase pathways, MAP kinase inhibitors may have potential use as therapeutic agents for CNV in AMD.

Original languageEnglish (US)
Pages (from-to)453-462
Number of pages10
JournalJournal of Cellular Physiology
Volume197
Issue number3
DOIs
StatePublished - Dec 2003

Fingerprint

Retinal Pigments
Transforming Growth Factors
Mitogen-Activated Protein Kinases
Vascular Endothelial Growth Factor A
Epithelial Cells
Choroidal Neovascularization
Choroid
Macular Degeneration
Cell Culture Techniques
Cell culture
Retinal Pigment Epithelium
Phosphotransferases
Retinal Neovascularization
RNA Isoforms
Activins
Inhibins
Staurosporine
Mitogen-Activated Protein Kinase Kinases
Therapeutic Uses
Diabetic Retinopathy

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells : Involvement of Mitogen-Activated Protein Kinases. / Nagineni, Chandrasekharam N.; Samuel, William; Nagineni, Sahrudaya; Pardhasaradhi, Komanduri; Wiggert, Barbara; Detrick, Barbara; Hooks, John J.

In: Journal of Cellular Physiology, Vol. 197, No. 3, 12.2003, p. 453-462.

Research output: Contribution to journalArticle

Nagineni, Chandrasekharam N. ; Samuel, William ; Nagineni, Sahrudaya ; Pardhasaradhi, Komanduri ; Wiggert, Barbara ; Detrick, Barbara ; Hooks, John J. / Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells : Involvement of Mitogen-Activated Protein Kinases. In: Journal of Cellular Physiology. 2003 ; Vol. 197, No. 3. pp. 453-462.
@article{acac18703aee4c04a9cff38886896ffe,
title = "Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells: Involvement of Mitogen-Activated Protein Kinases",
abstract = "Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age-related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a critical role in retinal disorders. We have examined the effects of various growth factors on the expression and secretion of VEGF by human retinal pigment epithelial cell cultures (HRPE). RT-PCR analyses revealed the presence of three isoforms of mRNA corresponding to VEGF 121, 165, and 189 that were up regulated by TGF-β1. TGF-β1, β2, and β3 were the potent inducers of VEGF secretion by HRPE cells whereas bFGF, PDGF, TGF-α, and GM-CSF had no effects. TGF-β receptor type II antibody significantly reversed induction of VEGF secretion by TGF-β. In contrast activin, inhibin and BMP, members of TGF-β super family, had no effects on VEGF expression in HRPE. VEGF mRNA levels and protein secretion induced by TGF-β were significantly inhibited by SB203580 and U0126, inhibitors of MAP kinases, but not by staurosporine and PDTC, protein kinase C and NF-κB pathway inhibitors, respectively. TGF-β also induced VEGF expression by fibroblasts derived from human choroid of eye. TGF-β induction of VEGF secretion by RPE and choroid cells may play a significant role in choroidal neovascularization (CNV) in AMD. Since the secretion of VEGF by HRPE is regulated by MAP kinase pathways, MAP kinase inhibitors may have potential use as therapeutic agents for CNV in AMD.",
author = "Nagineni, {Chandrasekharam N.} and William Samuel and Sahrudaya Nagineni and Komanduri Pardhasaradhi and Barbara Wiggert and Barbara Detrick and Hooks, {John J.}",
year = "2003",
month = "12",
doi = "10.1002/jcp.10378",
language = "English (US)",
volume = "197",
pages = "453--462",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells

T2 - Involvement of Mitogen-Activated Protein Kinases

AU - Nagineni, Chandrasekharam N.

AU - Samuel, William

AU - Nagineni, Sahrudaya

AU - Pardhasaradhi, Komanduri

AU - Wiggert, Barbara

AU - Detrick, Barbara

AU - Hooks, John J.

PY - 2003/12

Y1 - 2003/12

N2 - Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age-related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a critical role in retinal disorders. We have examined the effects of various growth factors on the expression and secretion of VEGF by human retinal pigment epithelial cell cultures (HRPE). RT-PCR analyses revealed the presence of three isoforms of mRNA corresponding to VEGF 121, 165, and 189 that were up regulated by TGF-β1. TGF-β1, β2, and β3 were the potent inducers of VEGF secretion by HRPE cells whereas bFGF, PDGF, TGF-α, and GM-CSF had no effects. TGF-β receptor type II antibody significantly reversed induction of VEGF secretion by TGF-β. In contrast activin, inhibin and BMP, members of TGF-β super family, had no effects on VEGF expression in HRPE. VEGF mRNA levels and protein secretion induced by TGF-β were significantly inhibited by SB203580 and U0126, inhibitors of MAP kinases, but not by staurosporine and PDTC, protein kinase C and NF-κB pathway inhibitors, respectively. TGF-β also induced VEGF expression by fibroblasts derived from human choroid of eye. TGF-β induction of VEGF secretion by RPE and choroid cells may play a significant role in choroidal neovascularization (CNV) in AMD. Since the secretion of VEGF by HRPE is regulated by MAP kinase pathways, MAP kinase inhibitors may have potential use as therapeutic agents for CNV in AMD.

AB - Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age-related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a critical role in retinal disorders. We have examined the effects of various growth factors on the expression and secretion of VEGF by human retinal pigment epithelial cell cultures (HRPE). RT-PCR analyses revealed the presence of three isoforms of mRNA corresponding to VEGF 121, 165, and 189 that were up regulated by TGF-β1. TGF-β1, β2, and β3 were the potent inducers of VEGF secretion by HRPE cells whereas bFGF, PDGF, TGF-α, and GM-CSF had no effects. TGF-β receptor type II antibody significantly reversed induction of VEGF secretion by TGF-β. In contrast activin, inhibin and BMP, members of TGF-β super family, had no effects on VEGF expression in HRPE. VEGF mRNA levels and protein secretion induced by TGF-β were significantly inhibited by SB203580 and U0126, inhibitors of MAP kinases, but not by staurosporine and PDTC, protein kinase C and NF-κB pathway inhibitors, respectively. TGF-β also induced VEGF expression by fibroblasts derived from human choroid of eye. TGF-β induction of VEGF secretion by RPE and choroid cells may play a significant role in choroidal neovascularization (CNV) in AMD. Since the secretion of VEGF by HRPE is regulated by MAP kinase pathways, MAP kinase inhibitors may have potential use as therapeutic agents for CNV in AMD.

UR - http://www.scopus.com/inward/record.url?scp=0345257178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345257178&partnerID=8YFLogxK

U2 - 10.1002/jcp.10378

DO - 10.1002/jcp.10378

M3 - Article

C2 - 14566975

AN - SCOPUS:0345257178

VL - 197

SP - 453

EP - 462

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 3

ER -